Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
Medicines and Healthcare products Regulatory Agency
National Institute of Biological Standards and Control
Potters Bar
NA
UK
Telephone: +44 1707641000
E-mail: purchasing@nibsc.org
NUTS: UKH23
Internet address(es)
Main address: https://mhra.bravosolution.co.uk/
I.4) Type of the contracting authority
National or federal agency/office
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Automated Immunohistochemical Slide Stainer
Reference number: P5309, ITT4135, ecm7127
II.1.2) Main CPV code
38000000
II.1.3) Type of contract
Supplies
II.1.4) Short description
The Agency is looking to purchase an automated immunohistochemical staining platform must be suitable for:
• single and duplex immunohistochemical staining in both chromogenic and fluorescent formats;
• automated running of single and multiplex RNAscope (chromogenic and fluorescent detection);
• automated running of BaseScope chromogenic identification protocols;
• must allow the use of researcher defined reagents/detection systems/protocols and protocol editing including defining incubation temperatures and times;
• have a footprint no larger than 800 mm (W)/720 mm (H)/780 mm (D) due to access and laboratory space constraints;
• produce staining intensities equivalent to current procedures using the same antibody dilutions to ensure consistency of results and analysis.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
120 000.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
National Institute of Biological Standards and Control, Blanche Lane, South Mimms,Potters Bar, Herts, EN6 3QG.
II.2.4) Description of the procurement
The Agency is looking to purchase an automated immunohistochemical staining platform must be suitable for:
• single and duplex immunohistochemical staining in both chromogenic and fluorescent formats;
• automated running of single and multiplex RNAscope (chromogenic and fluorescent detection);
• automated running of BaseScope chromogenic identification protocols;
• must allow the use of researcher defined reagents/detection systems/protocols and protocol editing including defining incubation temperatures and times;
• have a footprint no larger than 800 mm (W)/720 mm (H)/780 mm (D) due to access and laboratory space constraints;
• produce staining intensities equivalent to current procedures using the same antibody dilutions to ensure consistency of results and analysis.
We all also be looking for a contract for consumables and maintenance over the life of the equipment. The consumables and maintenance will be purchased as and when necessary and the contract for these is not guaranteed to go to the provider of the equipment.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2019/S 235-575296
Section V: Award of contract
Contract No: ecm7127
Title: Automated Slide Stainer
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
02/03/2020
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Leica MicroSystems
Milton Keynes
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 120 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
Medicines and Healthcare Products Regulatory Agency
London
UK
VI.4.2) Body responsible for mediation procedures
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf
London
E14 4PU
UK
VI.4.4) Service from which information about the review procedure may be obtained
Medicines and Healthcare Products Regulatory Agency
London
UK
VI.5) Date of dispatch of this notice
02/03/2020